@FiercePharma: Bloomberg: McNeil president ordered 'phantom recall.' Report | Follow @FiercePharma
> Sanofi-Aventis said it is buying the assets of Montreal's privately held skin care firm Canderm Pharma through its Canadian subsidiary. Release | Report
> GlaxoSmithKline's new kidney cancer drug Votrient won conditional approval from the European Commission, paving the way for its rollout across the European Union. Report
> When analyzing the value of a drug, more than half of patients look to cost, but only 4 percent of biopharma executives do, a new survey shows. Report
> Sigma Pharmaceuticals, the target of a takeover bid from Aspen Pharmacare Holdings, named a former chief financial officer to its top job after posting a record loss. Report
> Cipla, the Indian drugmaker that built a $1 billion business making generic HIV treatments, aims to sell copies of Roche's and Amgen's best- selling biotechnology medicines with a partner in China. Report
> Teva Pharmaceutical Industries launched its $2.5 billion bond offering to raise money to help finance its acquisition of German generics maker Ratiopharm. Report
> Medco Health Solutions has seen a benefit to its selling season for next year from a fight between rival pharmacy benefit manager CVS Caremark and drugstore chain Walgreen. Report
Biotech News
@FierceBiotech: Genmab CEO Lisa Drakeman (photo) bows out of the weakened biotech. Report | Follow @FierceBiotech
@JohnCFierce: On the ropes after TNFerade fiasco, GenVec considers its limited options. Report | Follow @JohnCFierce
> Amylin's Bydureon fails to impress in head-to-head trial. Report
> Cipla targets $19B biosimilar market with string of new deals. News
> GTC's CEO is out as company axes 50 staffers. Report
> Curis shares plunge after lead drug flunks cancer trial. Article
> On a roll, Neurocrine nails $575M licensing deal with Abbott. Story
Medical Device News
> Abbott Vascular cuts 120 jobs. Report
> FDA recalls fake surgical mesh. Story
> Dx company Veracyte lands $28M series B. Article
> Appeals court gives TriMed a win in patent dispute. Item
> Predictive Biosciences gains $25M for cancer Dx. Item
Drug Delivery News
> Savara wins $1.9M award for dry-powder tech. News
> New hybrid nanoparticles offer precise cell targeting. Report
> T-DM1 success inspires a wave of antibody-drug combos. Story
> "Smart" nanocapsules created for protein drug delivery. Report
> Injectable bone fluid can deliver stem cells, protein drugs. Article
And Finally... Fido can get his flu shot now, thanks to a newly approved shot to prevent H3N8 influenza from Intervet/Schering-Plough Animal Health. Report